Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Triapine in Combination With Gemcitabine in Recurrent/Unresectable/Metastatic Pancreatic Carcinoma

NCT00078975 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00078975
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00078975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Triapine in Combination With Gemcitabine in Recurrent/Unresectable/Metastatic Pancreatic Carcinoma
Lead sponsor
University Health Network, Toronto
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2004
Completion date
January 7, 2009
Enrollment
26 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer